JP2011020071A - Method for manufacturing polysulfone-based hollow fiber membrane - Google Patents
Method for manufacturing polysulfone-based hollow fiber membrane Download PDFInfo
- Publication number
- JP2011020071A JP2011020071A JP2009168347A JP2009168347A JP2011020071A JP 2011020071 A JP2011020071 A JP 2011020071A JP 2009168347 A JP2009168347 A JP 2009168347A JP 2009168347 A JP2009168347 A JP 2009168347A JP 2011020071 A JP2011020071 A JP 2011020071A
- Authority
- JP
- Japan
- Prior art keywords
- hollow fiber
- fiber membrane
- temperature
- polysulfone
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 125
- 239000012510 hollow fiber Substances 0.000 title claims abstract description 121
- 229920002492 poly(sulfone) Polymers 0.000 title claims abstract description 39
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims abstract description 78
- 238000009987 spinning Methods 0.000 claims abstract description 56
- 229920001477 hydrophilic polymer Polymers 0.000 claims abstract description 23
- 239000002904 solvent Substances 0.000 claims abstract description 21
- 239000011550 stock solution Substances 0.000 claims description 50
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 15
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 15
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 15
- 239000003960 organic solvent Substances 0.000 claims description 7
- 238000005345 coagulation Methods 0.000 claims description 6
- 230000015271 coagulation Effects 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 238000007599 discharging Methods 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 28
- 230000035699 permeability Effects 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 7
- 238000002156 mixing Methods 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 238000000746 purification Methods 0.000 abstract description 2
- 239000000010 aprotic solvent Substances 0.000 abstract 1
- 230000001112 coagulating effect Effects 0.000 abstract 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 7
- 238000005191 phase separation Methods 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004695 Polyether sulfone Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 229920006393 polyether sulfone Polymers 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920006316 polyvinylpyrrolidine Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- Artificial Filaments (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
Description
本発明は、高い透水性と膜強度を持つポリスルホン系中空糸膜の製造方法に関する。 The present invention relates to a method for producing a polysulfone-based hollow fiber membrane having high water permeability and membrane strength.
ポリスルホン系中空糸膜は、製膜が比較的容易で、幅広い孔径範囲の制御が可能であり、工業用ろ過膜や医療用の血液透析膜など多種類の分離膜として実用化されている。 Polysulfone-based hollow fiber membranes are relatively easy to produce and can be controlled over a wide range of pore diameters, and have been put to practical use as various types of separation membranes such as industrial filtration membranes and medical hemodialysis membranes.
ポリスルホン系中空糸膜の紡糸には、ジメチルアセトアミドやN−メチルピロリドンなどの非プロトン系有機溶媒が、ポリマーの溶媒として用いられることが多い。また、膜の孔径や空孔率を制御するために、紡糸ポリマー原液には、溶媒に対して相溶性を持つがポリマーに溶解しない非溶媒を添加することが多い。この非溶媒には、エチレングリコールやトリエチレングリコール、グリセリンなどの多価アルコールや、水などが使用されている。この中で、水は、ポリマーに対する非溶媒性が強いので、通常は紡糸ポリマー原液に対して数パーセントと少量で相分離性を制御できるために用いられることが多い。 In spinning of a polysulfone-based hollow fiber membrane, an aprotic organic solvent such as dimethylacetamide or N-methylpyrrolidone is often used as a solvent for the polymer. In order to control the pore size and porosity of the membrane, a non-solvent that is compatible with the solvent but not dissolved in the polymer is often added to the spinning polymer stock solution. As this non-solvent, polyhydric alcohols such as ethylene glycol, triethylene glycol, and glycerin, and water are used. Of these, water is often used because it has a strong non-solvent property with respect to the polymer, and thus it can usually control the phase separation in a few percent with respect to the spinning polymer stock solution.
特許文献1には、低温溶解型原液及びその製造方法が開示されている。具体的には、ポリスルホン系ポリマー15wt%、ポリビニルピロリドン8wt%、溶媒70〜82wt%および非溶媒0〜8wt%を80〜110℃で加熱溶解すること、前記加熱溶解した原液の相分離温度が25〜100℃であることが記載されている。そして、このような原液は、低温保存が楽で、半透膜としては特に大きな孔径を有するものの製造に有利に用いることができることが記載されている。 Patent Document 1 discloses a low-temperature dissolving stock solution and a production method thereof. Specifically, 15 wt% of a polysulfone polymer, 8 wt% of polyvinylpyrrolidone, 70 to 82 wt% of a solvent and 0 to 8 wt% of a non-solvent are heated and dissolved at 80 to 110 ° C, and the phase separation temperature of the heated and dissolved stock solution is 25. It is described that it is -100 degreeC. It is described that such a stock solution is easy to be stored at a low temperature and can be advantageously used for the production of a semipermeable membrane having a particularly large pore size.
特許文献2には、ポリスルホン系ポリマー16wt%、ポリエチレングリコール17.6wt%、ポリビニルピロリドン2.4wt%、ジメチルホルムアミド64wt%を120℃で加熱溶解し、140℃以上と9℃以下で相分離する製膜溶液を調製したこと、この製膜溶液を40℃または35℃に保ち、2重環状ノズルより吐出したことが記載されている。また、特許文献3には、ポリスルホン樹脂19wt%、ポリビニルピロリドン1.9wt%、ポリエチレングリコール30.4wt%、ジメチルホルムアミド48.7wt%を120℃で溶解し、75℃以上と29℃以下で相分離を起こす紡糸原液を得たこと、この紡糸原液を45℃に保ち、2重環状ノズルより吐出したことが記載されている。 In Patent Document 2, polysulfone-based polymer 16 wt%, polyethylene glycol 17.6 wt%, polyvinyl pyrrolidone 2.4 wt%, and dimethylformamide 64 wt% are heated and dissolved at 120 ° C., and phase separation is performed at 140 ° C. or higher and 9 ° C. or lower. It describes that a membrane solution was prepared and that this membrane-forming solution was kept at 40 ° C. or 35 ° C. and discharged from a double annular nozzle. Patent Document 3 discloses that polysulfone resin 19 wt%, polyvinyl pyrrolidone 1.9 wt%, polyethylene glycol 30.4 wt%, and dimethylformamide 48.7 wt% are dissolved at 120 ° C. and phase separated at 75 ° C. or higher and 29 ° C. or lower. It has been described that a spinning stock solution that causes stagnation was obtained and the spinning stock solution was kept at 45 ° C. and discharged from a double annular nozzle.
これらのポリスルホン系中空糸膜は、非対称構造を有するために膜強度が低く、そのため均一構造の膜に比べて膜厚を大きくする必要がある。一方、膜強度を高めるために、紡糸ポリマー原液中のポリマー濃度を高くすると、透水性能が低下してしまうという問題がある。 Since these polysulfone-based hollow fiber membranes have an asymmetric structure, the membrane strength is low. Therefore, it is necessary to increase the film thickness as compared with a membrane having a uniform structure. On the other hand, if the polymer concentration in the spinning polymer stock solution is increased in order to increase the membrane strength, there is a problem that the water permeability performance is lowered.
このような問題に対して、特許文献4には、紡糸ポリマー原液から不純物を除去するフィルターの孔径を一定範囲とし、吐出ノズルのスリット幅のバラツキを小さくすることにより、欠陥のない中空糸膜が得られることが開示されている。しかしながら、この方法は、欠陥に起因する膜強度の低下を抑制するものであって、膜自身の強度を向上させるものではなく、また、膜性能の向上についても期待することができない。 In order to solve such a problem, Patent Document 4 discloses a hollow fiber membrane having no defect by setting the pore diameter of a filter for removing impurities from a spinning polymer stock solution within a certain range and reducing the variation in the slit width of the discharge nozzle. It is disclosed that it can be obtained. However, this method suppresses a decrease in film strength caused by defects, does not improve the strength of the film itself, and cannot be expected to improve the film performance.
本発明は、かかる従来技術の現状に鑑み創案されたものであり、その目的は、高い透水性と膜強度を持ち、血液浄化器作成時の歩留りを高い水準で維持することができるポリスルホン系中空糸膜の製造方法を提供することにある。 The present invention was invented in view of the current state of the prior art, and the object thereof is a polysulfone-based hollow having high water permeability and membrane strength and capable of maintaining the yield at the time of creating a blood purifier at a high level. It is providing the manufacturing method of a thread film.
本発明者は、上記目的を達成するために鋭意検討した結果、中空糸膜の膜強度と透水性のためには紡糸ポリマー原液の保持温度と吐出温度の制御が重要であることを見出した。一般的に非プロトン系有機溶媒と非溶媒を用いたポリスルホン系中空糸膜の紡糸ポリマー原液は、溶解すると温度に対する安定性が高く、室温程度に温度を下げても凝固や相分離が発生しない。このため、ポリマーを高温下で完全に溶解させた後には、エネルギーコストを下げるため、紡糸ポリマー原液の温度を40℃程度に保つ。その後、紡糸ポリマー原液をノズルから吐出させるときには、吐出時の温度が膜の細孔径に影響を与えるので、目的とする中空糸膜細孔径に合わせた吐出ノズル温度を設定する。 As a result of intensive studies to achieve the above object, the present inventor has found that control of the holding temperature and the discharge temperature of the spinning polymer stock solution is important for the membrane strength and water permeability of the hollow fiber membrane. Generally, a spinning polymer stock solution of a polysulfone-based hollow fiber membrane using an aprotic organic solvent and a non-solvent has high temperature stability when dissolved, and does not cause coagulation or phase separation even when the temperature is lowered to about room temperature. For this reason, after the polymer is completely dissolved at a high temperature, the temperature of the spinning polymer stock solution is kept at about 40 ° C. in order to reduce the energy cost. Thereafter, when the spinning polymer stock solution is discharged from the nozzle, the discharge temperature affects the pore diameter of the membrane, so the discharge nozzle temperature is set in accordance with the target hollow fiber membrane pore diameter.
本発明者は、溶解した紡糸ポリマー原液の保持温度と吐出温度の中空糸膜の強度および膜性能に対する影響を詳細に検討した結果、紡糸ポリマー原液の保持温度と吐出温度を特定の温度範囲に制御することにより、中空糸膜の膜強度と透水性を向上できることを見出した。 As a result of detailed examination of the influence of the holding temperature and discharge temperature of the dissolved spinning polymer stock solution on the strength and membrane performance of the hollow fiber membrane, the inventor has controlled the holding temperature and discharge temperature of the spinning polymer stock solution within a specific temperature range. It was found that the membrane strength and water permeability of the hollow fiber membrane can be improved.
すなわち、本発明は以下の(1)〜(3)の構成を有するものである。
(1)ポリスルホン系ポリマー、親水性ポリマー、非プロトン系有機溶媒、及び非溶媒をタンク内に投入して混合した後、加熱して均一に溶解した紡糸ポリマー原液を、送液ラインに設けられたフィルターでろ過し、次いでノズルより吐出し、その後、凝固浴に浸漬する工程を含む中空糸膜の製造方法において、タンクからフィルターまでの紡糸ポリマー原液の温度を70〜95℃の範囲とし、ノズル吐出温度を前記温度より低く、40〜70℃の範囲とすることを特徴とするポリスルホン系中空糸膜の製造方法。
(2)紡糸ポリマー原液中の親水性ポリマーの質量割合がポリスルホン系ポリマーと親水性ポリマーの合計量に対して1〜20質量%であることを特徴とする(1)に記載のポリスルホン系中空糸膜の製造方法。
(3)親水性ポリマーがポリビニルピロリドンであることを特徴とする(1)又は(2)に記載のポリスルホン系中空糸膜の製造方法。
That is, the present invention has the following configurations (1) to (3).
(1) A polysulfone-based polymer, a hydrophilic polymer, an aprotic organic solvent, and a non-solvent were placed in a tank and mixed, and then a spinning polymer stock solution that was heated and uniformly dissolved was provided in the liquid-feeding line. In a hollow fiber membrane manufacturing method including a step of filtering through a filter, then discharging from a nozzle, and then immersing in a coagulation bath, the temperature of the spinning polymer stock solution from the tank to the filter is in the range of 70 to 95 ° C, and the nozzle is discharged A method for producing a polysulfone-based hollow fiber membrane, wherein the temperature is lower than the above temperature and is in the range of 40 to 70 ° C.
(2) The polysulfone-based hollow fiber according to (1), wherein the mass ratio of the hydrophilic polymer in the spinning polymer stock solution is 1 to 20 mass% with respect to the total amount of the polysulfone-based polymer and the hydrophilic polymer. A method for producing a membrane.
(3) The method for producing a polysulfone-based hollow fiber membrane according to (1) or (2), wherein the hydrophilic polymer is polyvinylpyrrolidone.
本発明のポリスルホン系中空糸膜の製造方法は、溶解した紡糸ポリマー原液を吐出するまでは通常より高い温度に保ち、吐出時には前記温度より低くしているので、中空糸膜の膜強度及び透水性が高く、しかも血液浄化器作成時の歩留りが高い。 The production method of the polysulfone-based hollow fiber membrane of the present invention is maintained at a temperature higher than usual until the dissolved spinning polymer stock solution is discharged, and is lower than the temperature at the time of discharge, so that the membrane strength and water permeability of the hollow fiber membrane are reduced. In addition, the yield when creating a blood purifier is high.
以下、本発明を詳細に説明する。
本発明は、非プロトン系有機溶媒と非溶媒を用いたポリスルホン系中空糸膜の紡糸ポリマー原液を、吐出ノズル部を除いて、70〜95℃の範囲の温度に維持し、吐出ノズル部でそれより低い温度に設定することにより、中空糸膜の強度と透水性が向上することを見出したものである。この現象の原因については、明確に分析できていないが、ポリマーの溶解状態が安定し、ポリマー鎖同士の絡み合いが進行することで、出来上がった膜の強度が増加すると共に、ノズルから吐出されたときに凝固が均一になり、スキン層の厚み斑が少なくなるためではないかと推察される。
Hereinafter, the present invention will be described in detail.
The present invention maintains a spinning polymer stock solution of a polysulfone-based hollow fiber membrane using an aprotic organic solvent and a non-solvent at a temperature in the range of 70 to 95 ° C., excluding the discharge nozzle portion. It has been found that the strength and water permeability of the hollow fiber membrane are improved by setting the temperature lower. Although the cause of this phenomenon has not been clearly analyzed, when the polymer is stabilized and the entanglement of the polymer chains proceeds, the strength of the resulting film increases and is discharged from the nozzle. It is presumed that the coagulation becomes uniform and the thickness unevenness of the skin layer decreases.
中空糸膜の強度が低下すると、血液浄化用透析器の生産時に、中空糸自体の糸折れや、破断が発生し、生産性が著しく低下する。また、臨床使用時に透析液側への血液の漏出の危険性が高くなるという問題がある。本発明の製造方法で得られる中空糸膜は、この問題をクリアするために、中空糸1本あたりの破断強力が14g以上、さらには15g以上である。 When the strength of the hollow fiber membrane is reduced, the hollow fiber itself is broken or broken during the production of the blood purification dialyzer, and the productivity is significantly reduced. In addition, there is a problem that the risk of blood leakage to the dialysate increases during clinical use. In order to clear this problem, the hollow fiber membrane obtained by the production method of the present invention has a breaking strength per hollow fiber of 14 g or more, and further 15 g or more.
また、本発明の製造方法で得られる中空糸膜は、200〜450ml/(m2・hr・mmHg)の透水性(UFR)を有する。UFRが200ml/(m2・hr・mmHg)未満の場合は、透析膜として必要な低分子タンパク質の除去能を得られないことがあり、UFRが450ml/(m2・hr・mmHg)より大きい場合は、タンパク質の漏出を抑えきれないことがある。臨床使用中にタンパク質の漏出量が増大すると、生体内の血中タンパク質濃度が低くなり、低タンパク症を引き起こす恐れがある。UFRの下限は、250ml/(m2・hr・mmHg)以上がより好ましく、300ml/(m2・hr・mmHg)以上がさらに好ましい。UFRの上限は、420ml/(m2・hr・mmHg)以下がより好ましく、400ml/(m2・hr・mmHg)以下がさらに好ましい。 The hollow fiber membrane obtained by the production method of the present invention has a water permeability (UFR) of 200 to 450 ml / (m 2 · hr · mmHg). When the UFR is less than 200 ml / (m 2 · hr · mmHg), the ability to remove low molecular weight proteins required as a dialysis membrane may not be obtained, and the UFR is greater than 450 ml / (m 2 · hr · mmHg). In some cases, protein leakage may not be suppressed. When the amount of protein leakage increases during clinical use, the blood protein concentration in the living body is lowered, which may cause hypoproteinosis. The lower limit of UFR is more preferably 250 ml / (m 2 · hr · mmHg) or more, and further preferably 300 ml / (m 2 · hr · mmHg) or more. The upper limit of UFR is more preferably 420 ml / (m 2 · hr · mmHg) or less, and further preferably 400 ml / (m 2 · hr · mmHg) or less.
中空糸膜の紡糸ポリマー原液は、吐出ノズル部を除いて70〜95℃の温度に維持される。維持温度を70℃未満とすると、紡糸ポリマー原液が不安定となり糸強度が低下したり、透水性が低下することがあり、維持温度を95℃より高くすると、紡糸ポリマー原液の熱劣化が進むので、好ましくない。下限の温度は、72℃以上がより好ましく、75℃以上が特に好ましい。上限の温度は、90℃以下がより好ましく、85℃以下が特に好ましい。 The spinning polymer stock solution of the hollow fiber membrane is maintained at a temperature of 70 to 95 ° C. except for the discharge nozzle portion. If the maintenance temperature is less than 70 ° C, the spinning polymer stock solution may become unstable, resulting in a decrease in yarn strength or water permeability. If the maintenance temperature is higher than 95 ° C, thermal degradation of the spinning polymer stock solution will proceed. It is not preferable. The lower limit temperature is more preferably 72 ° C. or higher, and particularly preferably 75 ° C. or higher. The upper limit temperature is more preferably 90 ° C. or less, and particularly preferably 85 ° C. or less.
本発明の製造方法では、紡糸ポリマー原液のノズル吐出部の温度は、上記維持温度の範囲より低く設定する。これは、出来上がった中空糸膜の構造や性能に吐出温度が大きな影響を与えるためである。具体的には、紡糸ポリマー原液の吐出温度を40〜70℃の範囲に設定する。40℃未満とすると、透水性が低下することがあり、70℃より高くすると、中空糸膜を臨床使用したときにタンパク質の漏出量が増大する恐れがあるため、好ましくない。下限の温度は、45℃以上とすることが好ましく、48℃以上がより好ましく、50℃以上が特に好ましい。上限の温度は、65℃以下が好ましく、62℃以下が好ましく、60℃以下がより好ましい。 In the production method of the present invention, the temperature of the nozzle discharge portion of the spinning polymer stock solution is set to be lower than the range of the maintenance temperature. This is because the discharge temperature greatly affects the structure and performance of the completed hollow fiber membrane. Specifically, the discharge temperature of the spinning polymer stock solution is set in the range of 40 to 70 ° C. When the temperature is lower than 40 ° C., the water permeability may be lowered. When the temperature is higher than 70 ° C., the amount of protein leakage may increase when the hollow fiber membrane is clinically used. The lower limit temperature is preferably 45 ° C. or higher, more preferably 48 ° C. or higher, and particularly preferably 50 ° C. or higher. The upper limit temperature is preferably 65 ° C. or less, preferably 62 ° C. or less, and more preferably 60 ° C. or less.
ただし、紡糸ポリマー原液のノズル吐出温度を上記維持温度より低くする場合にその状態の時間が長いと、紡糸ポリマー原液が不安定となるので、1時間以内が好ましく、30分以内がより好ましい。このようにするためには、紡糸ポリマー原液を溶解して移送する部分とノズル吐出部分の熱媒を分割し、吐出部分のみを他の部分より低い温度に設定することと、低い温度に設定した吐出部分の紡糸ポリマー原液の滞留体積を、吐出速度より計算し、滞留時間を上記のように短くすることが必要である。 However, when the nozzle discharge temperature of the spinning polymer stock solution is made lower than the above maintenance temperature, if the time of the state is long, the spinning polymer stock solution becomes unstable, and therefore it is preferably within 1 hour, more preferably within 30 minutes. In order to do this, the heat transfer medium of the part where the spinning polymer stock solution is dissolved and transferred and the nozzle discharge part are divided, and only the discharge part is set to a lower temperature than the other part, and the temperature is set to a lower temperature. It is necessary to calculate the retention volume of the spinning polymer stock solution at the discharge portion from the discharge speed and to shorten the retention time as described above.
本発明の製造方法では、紡糸ポリマー原液のノズル吐出部前の温度を70〜95℃とするが、原料のポリスルホン系ポリマー、溶媒、非溶媒を溶解タンクに投入する際には、この温度範囲とすることは困難である。従って、本発明では、この温度の適用範囲は、ポリマーの溶解が行われるタンクからノズルの吐出前のろ過フィルターまでとする。 In the production method of the present invention, the temperature before the nozzle discharge portion of the spinning polymer stock solution is set to 70 to 95 ° C., but when the raw material polysulfone polymer, solvent, and non-solvent are charged into the dissolution tank, It is difficult to do. Therefore, in the present invention, the applicable range of this temperature is from the tank in which the polymer is dissolved to the filtration filter before discharge of the nozzle.
本発明の製造方法で使用する紡糸ポリマー原液は、ポリスルホン系ポリマー、親水性ポリマー、非プロトン系有機溶媒、及び非溶媒をタンク内に投入して混合した後、加熱して均一に溶解して得られるものである。 The spinning polymer stock solution used in the production method of the present invention is obtained by mixing a polysulfone-based polymer, a hydrophilic polymer, an aprotic organic solvent, and a non-solvent into a tank and mixing them, followed by heating to obtain a uniform solution. It is what
ポリスルホン系ポリマーは、スルホン結合を有するポリマーの総称であり、特に限定されないが、例えば以下で示される繰り返し単位を持つポリスルホンやポリエーテルスルホンが挙げられる。これらは広く市販されており、入手も容易なため好ましく使用される。
親水性ポリマーとしては、ポリスルホン系ポリマーとミクロな相分離構造を形成するものが好ましく使用される。例えば、ポリエチレングリコール、ポリビニルアルコール、カルボキシメチルセルロース、ポリビニルピロリドン等を挙げることができるが、安全性や経済性の面よりポリビニルピロリドンが好ましい。ポリビニルピロリドンは、N−ビニルピロリドンをビニル重合させた水溶性の高分子化合物であり、BASF社より「コリドン」、ISP社より「プラスドン」、第一工業製薬社より「ピッツコール」の商品名で市販されており、それぞれ各種の分子量の製品がある。一般には、親水性の付与効率では低分子量のもの、一方、溶出量を低くする点では高分子量のものが好適であるが、最終製品の中空糸膜束の要求特性に合わせて適宜選択される。単一の分子量のものを用いても良いし、分子量の異なる製品を2種以上混合して用いても良い。また、市販の製品を精製し、例えば分子量分布をシャープにしたものを用いても良い。 As the hydrophilic polymer, those that form a micro phase separation structure with a polysulfone polymer are preferably used. For example, polyethylene glycol, polyvinyl alcohol, carboxymethyl cellulose, polyvinyl pyrrolidone and the like can be mentioned, and polyvinyl pyrrolidone is preferable from the viewpoint of safety and economy. Polyvinyl pyrrolidone is a water-soluble polymer compound obtained by vinyl polymerization of N-vinyl pyrrolidone. The product names are “Collidon” from BASF, “Prasdon” from ISP, and “Pittscall” from Daiichi Kogyo Seiyaku. There are products of various molecular weights that are commercially available. In general, a low molecular weight is preferred for imparting hydrophilicity, while a high molecular weight is suitable for reducing the amount of elution, but it is appropriately selected according to the required characteristics of the hollow fiber membrane bundle of the final product. . Those having a single molecular weight may be used, or two or more products having different molecular weights may be mixed and used. Moreover, you may use what refine | purified a commercial product and sharpened molecular weight distribution, for example.
非プロトン系有機溶媒としては、ジメチルアセトアミド、ジメチルスルホキシド、N−メチルピロリドン、ジメチルホルムアミド等が挙げられ、これらを単独で、もしくは混合した状態で使用することができる。この中でもジメチルアセトアミドやN−メチルピロリドンは、ポリスルホン系ポリマーの溶解性が高く、比較的高い沸点を持ち、安全性も高いので、好適に使用することができる。 Examples of the aprotic organic solvent include dimethylacetamide, dimethylsulfoxide, N-methylpyrrolidone, dimethylformamide and the like, and these can be used alone or in a mixed state. Among these, dimethylacetamide and N-methylpyrrolidone can be preferably used because the polysulfone-based polymer has high solubility, a relatively high boiling point, and high safety.
非溶媒は、溶媒と相溶性を持つが、ポリスルホン系ポリマーは溶解しない性質を有し、紡糸ポリマー原液の相分離を促進し、制御する役割を持つ。非溶媒としては、エチレングリコール、ジエチレングリコール、トリエチレングリコール、グリセリンなどの多価アルコール、水などが挙げられる。 The non-solvent is compatible with the solvent, but the polysulfone polymer does not dissolve, and has a role of promoting and controlling phase separation of the spinning polymer stock solution. Examples of the non-solvent include polyhydric alcohols such as ethylene glycol, diethylene glycol, triethylene glycol, and glycerin, and water.
紡糸ポリマー原液は、上記の原料をタンク内で混合した後、加熱して均一に溶解することによって得られるが、この紡糸ポリマー原液はタンクから送液ラインを経てノズルに送られる。このとき送液ラインに設けられたフィルターにより紡糸ポリマー原液中の不溶成分やゲルがろ過除去される。かくして得られた紡糸ポリマー原液は、ノズルから吐出され、凝固浴に浸漬されて中空糸膜を形成し、中空糸膜を水洗、乾燥する工程を経て最終製品になる。 The spinning polymer stock solution is obtained by mixing the above raw materials in a tank and then heating to uniformly dissolve the spinning polymer stock solution. The spinning polymer stock solution is sent from the tank to a nozzle through a liquid feeding line. At this time, insoluble components and gel in the spinning polymer stock solution are filtered and removed by a filter provided in the liquid feeding line. The spinning polymer stock solution thus obtained is discharged from a nozzle, immersed in a coagulation bath to form a hollow fiber membrane, and the hollow fiber membrane is washed with water and dried to become a final product.
本発明のポリスルホン系中空糸膜の製造方法は、紡糸ポリマー原液の保持温度及びノズル吐出温度以外は、基本的に従来公知の方法を採用することができ、例えば特開2000−300663号公報に記載される方法を採用することができる。具体的に例示すると、まずポリエーテルスルホン(4800P、住友化学社製)16質量%、ポリビニルピロリドン(K−90、BASF社製)5質量%、ジメチルアセトアミド74質量%、水5質量%をタンク内に投入して混合した後、加熱して均一に溶解して紡糸ポリマー原液を得る。これを脱泡し、フィルターでろ過した後、50%ジメチルアセトアミド水溶液を芯液として2重管オリフィスノズルの外側、内側より同時に吐出し、50cmの空走部を経て、75℃の水からなる凝固浴中に導き、中空糸膜を形成し、水洗後に巻きとり、60℃で乾燥する方法が挙げられる。 As the method for producing the polysulfone-based hollow fiber membrane of the present invention, conventionally known methods can be basically employed except for the spinning polymer stock solution holding temperature and the nozzle discharge temperature, for example, as described in JP-A No. 2000-300663 Can be employed. Specifically, first, 16% by mass of polyethersulfone (4800P, manufactured by Sumitomo Chemical Co., Ltd.), 5% by mass of polyvinylpyrrolidone (K-90, manufactured by BASF), 74% by mass of dimethylacetamide, and 5% by mass of water are contained in the tank. Then, the mixture is heated and uniformly dissolved to obtain a spinning polymer stock solution. After defoaming and filtering with a filter, 50% dimethylacetamide aqueous solution is discharged as a core solution simultaneously from the outside and inside of the double-tube orifice nozzle, solidified by 75 ° C water through a 50 cm free running part. A method of introducing into a bath, forming a hollow fiber membrane, winding up after washing with water, and drying at 60 ° C. can be mentioned.
本発明では、紡糸ポリマー原液中の親水性ポリマーの質量割合は、ポリスルホン系ポリマーと親水性ポリマーの合計量に対して1〜20質量%であることが好ましい。ポリスルホン系ポリマーに対してポリビニルピロリドンの割合が少なすぎる場合、膜の親水性付与効果が不足する可能性がある。従って、質量割合の下限は、1.5質量%以上が好ましく、2.0質量%以上がより好ましく、2.5質量%以上がさらに好ましい。一方、該割合が多すぎると、親水性付与効果が飽和し、かつポリビニルピロリドンおよび/または酸化劣化物の膜からの溶出量が増大し、ポリビニルピロリドンの膜からの溶出量が10ppmを超える場合がある。従って、質量割合の上限は、18質量%以下が好ましく、15質量%以下がより好ましく、13質量%以下がさらに好ましく、10質量%以下が特に好ましい。 In the present invention, the mass ratio of the hydrophilic polymer in the spinning polymer stock solution is preferably 1 to 20 mass% with respect to the total amount of the polysulfone polymer and the hydrophilic polymer. If the proportion of polyvinylpyrrolidone is too small relative to the polysulfone-based polymer, the effect of imparting hydrophilicity to the membrane may be insufficient. Therefore, the lower limit of the mass ratio is preferably 1.5% by mass or more, more preferably 2.0% by mass or more, and further preferably 2.5% by mass or more. On the other hand, if the ratio is too large, the effect of imparting hydrophilicity is saturated, and the amount of polyvinylpyrrolidone and / or oxidatively deteriorated material eluted from the membrane increases, and the amount of polyvinylpyrrolidone eluted from the membrane may exceed 10 ppm. is there. Therefore, the upper limit of the mass ratio is preferably 18% by mass or less, more preferably 15% by mass or less, further preferably 13% by mass or less, and particularly preferably 10% by mass or less.
中空糸膜の膜構造に関しては均一構造に近いスポンジ構造を有するものや、近年、透析効率を向上させる目的で実質的に選択分離を行う緻密層と空隙率が高く膜強度を維持する支持層の組み合わせからなるものがある。しかし、いずれの中空糸膜にせよ老廃物の選択透過を決定する因子は主にスポンジ構造、あるいは緻密層の膜構造であり、通常は被処理液と接触する部分に存在する。また、乾燥状態での膜を形成するポリマーの様態は紡糸原液におけるポリマー濃度や孔構造を形成させる相分離を促す溶媒、非溶媒の比率、紡糸口金の温度等によって制御が可能でポリマー粒子の集合体のような膜構造とポリマー同士が線状に絡み合ったような網目状構造を有するものが存在する。本発明では、膜がポリマー粒子の集合体のような膜構造を形成するよう、紡糸原液中のポリマー濃度を曳糸性の限界よりもやや高めに設定することが好ましい。紡糸原液中のポリマー濃度は、例えばポリエーテルスルホンであれば16質量%以上にすることが好ましい。 The membrane structure of the hollow fiber membrane has a sponge structure close to a uniform structure, and in recent years, a dense layer that performs substantially selective separation for the purpose of improving dialysis efficiency and a support layer that maintains membrane strength with a high porosity. There are some combinations. However, in any hollow fiber membrane, the factor that determines the permeation of the waste is mainly the sponge structure or the membrane structure of the dense layer, and usually exists in the portion in contact with the liquid to be treated. The state of the polymer that forms the membrane in the dry state can be controlled by the polymer concentration in the spinning dope, the solvent that promotes phase separation that forms the pore structure, the ratio of non-solvent, the temperature of the spinneret, etc. Some have a membrane structure such as a body and a network structure in which polymers are intertwined linearly. In the present invention, the polymer concentration in the spinning dope is preferably set slightly higher than the spinnability limit so that the membrane forms a membrane structure like an aggregate of polymer particles. For example, in the case of polyethersulfone, the polymer concentration in the spinning dope is preferably 16% by mass or more.
本発明のポリスルホン系中空糸膜の内径は、100〜300μmであることが好ましい。内径が100μm未満の場合には、中空糸膜の圧力損失が大きくなるため、血液を流した際に溶血することがある。従って、内径の下限は、130μm以上がより好ましく、150μm以上がさらに好ましい。逆に、内径が300μmより大きい場合には、中空糸膜内を流れる血液の剪断速度が小さく、ろ過に伴いタンパク質などが膜の内面に堆積しやすくなる傾向がある。従って、内径の上限は、280μm以下がより好ましく、260μm以下がさらに好ましい。 The inner diameter of the polysulfone-based hollow fiber membrane of the present invention is preferably 100 to 300 μm. When the inner diameter is less than 100 μm, the pressure loss of the hollow fiber membrane increases, so that hemolysis may occur when blood is flowed. Therefore, the lower limit of the inner diameter is more preferably 130 μm or more, and further preferably 150 μm or more. On the contrary, when the inner diameter is larger than 300 μm, the shear rate of blood flowing in the hollow fiber membrane is low, and there is a tendency that proteins and the like are easily deposited on the inner surface of the membrane with filtration. Therefore, the upper limit of the inner diameter is more preferably 280 μm or less, and further preferably 260 μm or less.
本発明のポリスルホン系中空糸膜の膜厚は20〜100μmであることが好ましい。膜厚が20μm未満の場合には、中空糸膜の可紡性や血液浄化器の組み立て性が非常に悪くなる。従って、膜厚の下限は、21μm以上がより好ましく、22μm以上がさらに好ましい。逆に、膜厚が100μmより大きい場合には、透過性能が悪くなる傾向にあり、タンパク質などが膜に吸着しやすくなる傾向がある。従って、膜厚の上限は、50μm以下がより好ましく、35μm以下がさらに好ましい。 The film thickness of the polysulfone-based hollow fiber membrane of the present invention is preferably 20 to 100 μm. When the film thickness is less than 20 μm, the spinnability of the hollow fiber membrane and the assemblability of the blood purifier are very poor. Therefore, the lower limit of the film thickness is more preferably 21 μm or more, and further preferably 22 μm or more. On the contrary, when the film thickness is larger than 100 μm, the permeation performance tends to deteriorate, and proteins and the like tend to be easily adsorbed to the film. Therefore, the upper limit of the film thickness is more preferably 50 μm or less, and further preferably 35 μm or less.
以下、実施例により本発明の効果を示すが、本発明はこれらに何ら限定されるものではない。 Hereinafter, although the effect of the present invention is shown by an example, the present invention is not limited to these at all.
(膜中の親水性ポリマーの質量割合)
親水性ポリマーとしてポリビニルピロリドン(PVP)を用いた場合の測定法を示す。中空糸膜を、真空乾燥器を用いて80℃で48時間乾燥させ、その10mgをCHNコーダー(ヤナコ分析工業社製、MT−6型)で分析し、窒素含有量からPVPの質量割合を下記式で計算し求めた。
親水性ポリマーの質量割合(質量%)=窒素含有量(質量%)×111/14
(Mass ratio of hydrophilic polymer in membrane)
The measurement method when polyvinylpyrrolidone (PVP) is used as the hydrophilic polymer is shown. The hollow fiber membrane was dried at 80 ° C. for 48 hours using a vacuum dryer, 10 mg of which was analyzed with a CHN coder (manufactured by Yanaco Analytical Industrial Co., Ltd., MT-6 type), and the mass ratio of PVP from the nitrogen content was as follows: Calculated by the formula.
Mass ratio (mass%) of hydrophilic polymer = nitrogen content (mass%) × 111/14
(中空糸膜の膜厚)
中空糸膜の断面を倍率200倍の投影機で投影し、各視野内で最大、最小、中程度の大きさの中空糸の内径(A)および外径(B)を測定し、各中空糸の膜厚を次式で求め、30視野90個の中空糸の膜厚の平均を算出した。
膜厚(μm)=(B−A)/2
(Hollow fiber membrane thickness)
The cross-section of the hollow fiber membrane is projected with a projector having a magnification of 200 times, and the inner diameter (A) and outer diameter (B) of the hollow fiber of maximum, minimum, and medium sizes are measured in each field of view. The average film thickness of 90 hollow fibers of 30 fields of view was calculated.
Film thickness (μm) = (B−A) / 2
(破断強度)
有効試料長10cmの中空糸試験片に対して、テンシロン(東洋ボールドウィン製UTM11)でクロスヘッドスピード10cmの条件で引張り試験を行ない、破断点を測定した。サンプルは30本を測定し、平均値を結果とした。測定は、20±5℃、60±10%RHの温湿度環境下で実施した。中空糸が湿潤状態のものは、測定環境下で24hrの放置を行ない、実質的に乾燥状態となったものを用いて実施した。
(Breaking strength)
A tensile test was performed on a hollow fiber test piece having an effective sample length of 10 cm using Tensilon (UTM11 manufactured by Toyo Baldwin) at a crosshead speed of 10 cm, and the breaking point was measured. Thirty samples were measured and the average value was taken as the result. The measurement was performed in a temperature and humidity environment of 20 ± 5 ° C. and 60 ± 10% RH. When the hollow fiber was in a wet state, the hollow fiber was allowed to stand for 24 hours in a measurement environment, and the hollow fiber was substantially dried.
(純水の限外濾過係数(UFR))
血液浄化器を使用し、膜の内外両面に純水を満たし、37℃に恒温した。膜の内側に通じる血液浄化器入口から圧力をかけて37度の純水を流し、膜の内側と外側の圧力差、すなわち膜間圧力差を生じせしめ、1分間に膜を通じて膜外側に出てくる純水の量を測定した。膜間圧力差(TMP)はTMP=(Pi+Po)/2とする(Piは血液浄化器入口圧力、Poは血液浄化器出口圧力)。4点の異なった膜間圧力差において、1分間の透水量を測定し、膜間圧力差と透水量の2次元座標にプロットして、それらの近似直線の傾きを求めた。この数値に60を掛け、血液浄化器の膜面積で割って中空糸膜の純水の限外濾過係数(UFR)を求めた。UFRの単位はml/(m2・hr・mmHg)である。
(Ultrafiltration coefficient of pure water (UFR))
Using a blood purifier, the inner and outer surfaces of the membrane were filled with pure water, and the temperature was kept constant at 37 ° C. A 37-degree pure water is flowed by applying pressure from the blood purifier inlet leading to the inside of the membrane, causing a pressure difference between the inside and outside of the membrane, that is, a pressure difference between the membranes, and exiting outside the membrane through the membrane in 1 minute. The amount of pure water coming was measured. The transmembrane pressure difference (TMP) is set to TMP = (Pi + Po) / 2 (Pi is the blood purifier inlet pressure, Po is the blood purifier outlet pressure). At four different transmembrane pressure differences, the water permeation amount for 1 minute was measured, plotted on the two-dimensional coordinates of the transmembrane pressure difference and the water permeation amount, and the slopes of these approximate lines were obtained. This value was multiplied by 60 and divided by the membrane area of the blood purifier to obtain the ultrafiltration coefficient (UFR) of pure water of the hollow fiber membrane. The unit of UFR is ml / (m 2 · hr · mmHg).
(リーク試験)
クエン酸を添加し、凝固を抑制した37℃の牛血液を、10000本の中空糸が充填された血液浄化器に200mL/minで送液し、10mL/minの割合で血液を濾過する。このとき、ろ液は血液に戻し、循環系とする。60分間後に血液浄化器のろ液を採取し、血液浄化器のケースを破壊し、中空糸束中の赤血球のリークに起因する赤色を目視で観察し、血液リークした血液浄化器中の中空糸の本数を調べた。
(Leak test)
A 37 ° C. bovine blood to which citric acid was added and coagulation was suppressed was fed to a blood purifier filled with 10,000 hollow fibers at 200 mL / min, and the blood was filtered at a rate of 10 mL / min. At this time, the filtrate is returned to blood to be a circulatory system. After 60 minutes, the filtrate of the blood purifier is collected, the case of the blood purifier is destroyed, the red color resulting from the leakage of red blood cells in the hollow fiber bundle is visually observed, and the hollow fiber in the blood purifier that has leaked blood The number of was examined.
(実施例1)
ポリエーテルスルホン(住化ケムテックス社製、スミカエクセル(R)5200P)17.0質量%、ポリビニルピロリドン(BASF社製コリドン(R)K−90)3.0質量%、ジメチルアセトアミド(DMAc)77.0質量%、RO水3.0質量%の組成の原料をタンクに投入して混合した後、90℃で均一に攪拌溶解した。次いで真空ポンプを用いて系内を−500mmHgまで減圧した後、溶媒等が蒸発して組成が変化しないように直ぐに系内を密閉し15分間放置した。この操作を3回繰り返して紡糸ポリマー原液の脱泡を行った。紡糸ポリマー原液を、90℃の温度に保持した送液ラインに通し、30μm、15μmの2種の焼結フィルターに順に通した後、55℃の温度に維持したチューブインオリフィスノズルから中空形成剤として予め−700mmHgで30分間脱気処理した40質量%DMAc水溶液を用いて吐出させ、紡糸管により外気と遮断された600mmのエアーギャップ部を通過後、70℃の20質量%DMAc水溶液中で凝固させ、湿潤状態のまま綛に捲き上げた。使用したチューブインオリフィスノズルのノズルスリット幅は、平均60μmであり、最大61μm、最小59μm、スリット幅の最大値、最小値の比は1.03、製膜溶液のドラフト比は1.06、乾式部の絶対湿度は0.18kg/kg乾燥空気であった。紡糸工程中、中空糸膜が接触するローラーは表面が鏡面加工されたステンレス製のもの、ガイドはすべて表面が梨地加工されたステンレス製のものを使用した。
Example 1
17.0% by mass of polyethersulfone (manufactured by Sumika Chemtex, Sumika Excel (R) 5200P), 3.0% by mass of polyvinylpyrrolidone (Collidon (R) K-90, manufactured by BASF), 77% dimethylacetamide (DMAc). A raw material having a composition of 0% by mass and 3.0% by mass of RO water was put into a tank and mixed, and then uniformly stirred and dissolved at 90 ° C. Next, after reducing the pressure in the system to −500 mmHg using a vacuum pump, the system was immediately sealed and allowed to stand for 15 minutes so that the solvent did not evaporate and the composition changed. This operation was repeated three times to degas the spinning polymer stock solution. The spinning polymer stock solution is passed through a liquid feed line maintained at a temperature of 90 ° C., passed through two kinds of sintered filters of 30 μm and 15 μm in order, and then used as a hollow forming agent from a tube-in orifice nozzle maintained at a temperature of 55 ° C. It was discharged using a 40% by mass DMAc aqueous solution that had been degassed at −700 mmHg for 30 minutes in advance, and after passing through a 600 mm air gap part that was blocked from the outside air by a spinning tube, it was solidified in a 20% by mass DMAc aqueous solution at 70 ° C. Then, it was rolled up in a wet state. The nozzle slit width of the used tube-in-orifice nozzle is an average of 60 μm, the maximum 61 μm, the minimum 59 μm, the ratio of the maximum and minimum slit width is 1.03, the draft ratio of the film forming solution is 1.06, and the dry type The absolute humidity of the part was 0.18 kg / kg dry air. During the spinning process, the roller in contact with the hollow fiber membrane was made of stainless steel whose surface was mirror-finished, and the guides were all made of stainless steel whose surface was textured.
該中空糸膜約10000本の束の周りに中空糸束側表面が梨地加工されたポリエチレン製のフィルムを巻きつけた後、80℃の熱水中で30分間×4回洗浄し、洗浄終了後40℃の窒素雰囲気中で乾燥処理を行った。得られた中空糸膜の内径は200.2μm、膜厚は31.0μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.5質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり15.6gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所は認められなかった。実施例1の中空糸膜の製造条件及び評価結果を表1に示す。 After wrapping about 10,000 bundles of the hollow fiber membranes, a polyethylene film having a hollow surface on the hollow fiber bundle side surface is wound, and then washed in hot water at 80 ° C. for 30 minutes × 4 times, after the washing is completed. Drying was performed in a nitrogen atmosphere at 40 ° C. The resulting hollow fiber membrane had an inner diameter of 200.2 μm and a film thickness of 31.0 μm. It was 4.5 mass% when the mass ratio of the hydrophilic polymer in a hollow fiber membrane was measured. When the yarn strength of the hollow fiber was measured, the breaking strength was 15.6 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membrane thus obtained and conducting a leak test, no leak due to breakage or breakage of the hollow fiber was observed. The production conditions and evaluation results of the hollow fiber membrane of Example 1 are shown in Table 1.
(実施例2)
紡糸ポリマー原液のタンクからフィルターまでの温度を75℃に保持した以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は200.1μm、膜厚は30.5μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.5質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり15.2gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所は認められなかった。実施例2の中空糸膜の製造条件及び評価結果を表1に示す。
(Example 2)
A hollow fiber membrane bundle was obtained in the same manner as in Example 1 except that the temperature from the spinning polymer stock solution to the filter was maintained at 75 ° C. The resulting hollow fiber membrane had an inner diameter of 200.1 μm and a film thickness of 30.5 μm. It was 4.5 mass% when the mass ratio of the hydrophilic polymer in a hollow fiber membrane was measured. When the yarn strength of the hollow fiber was measured, the breaking strength was 15.2 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membrane thus obtained and conducting a leak test, no leak due to breakage or breakage of the hollow fiber was observed. Table 1 shows the production conditions and evaluation results of the hollow fiber membrane of Example 2.
(実施例3)
紡糸ポリマー原液のタンクからフィルターまでの温度を80℃に保持した以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は200.3μm、膜厚は30.5μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.5質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり15.3gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所は認められなかった。実施例3の中空糸膜の製造条件及び評価結果を表1に示す。
(Example 3)
A hollow fiber membrane bundle was obtained in the same manner as in Example 1 except that the temperature from the spinning polymer stock solution to the filter was maintained at 80 ° C. The resulting hollow fiber membrane had an inner diameter of 200.3 μm and a film thickness of 30.5 μm. It was 4.5 mass% when the mass ratio of the hydrophilic polymer in a hollow fiber membrane was measured. When the yarn strength of the hollow fiber was measured, the breaking strength was 15.3 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membrane thus obtained and conducting a leak test, no leak due to breakage or breakage of the hollow fiber was observed. The production conditions and evaluation results of the hollow fiber membrane of Example 3 are shown in Table 1.
(実施例4)
紡糸ポリマー原液のタンクからフィルターまでの温度を80℃に保持し、ノズル温度を45℃とした以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は199.9μm、膜厚は30.0μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.4質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり15.6gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所は認められなかった。実施例4の中空糸膜の製造条件及び評価結果を表1に示す。
Example 4
A hollow fiber membrane bundle was obtained in the same manner as in Example 1 except that the temperature from the spinning polymer stock solution to the filter was maintained at 80 ° C and the nozzle temperature was 45 ° C. The obtained hollow fiber membrane had an inner diameter of 199.9 μm and a film thickness of 30.0 μm. The mass ratio of the hydrophilic polymer in the hollow fiber membrane was measured and found to be 4.4 mass%. When the yarn strength of the hollow fiber was measured, the breaking strength was 15.6 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membrane thus obtained and conducting a leak test, no leak due to breakage or breakage of the hollow fiber was observed. The production conditions and evaluation results of the hollow fiber membrane of Example 4 are shown in Table 1.
(実施例5)
紡糸ポリマー原液のタンクからフィルターまでの温度を80℃に保持し、ノズル温度を65℃とした以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は201.1μm、膜厚は30.6μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.5質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり15.1gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所は認められなかった。実施例5の中空糸膜の製造条件及び評価結果を表1に示す。
(Example 5)
A hollow fiber membrane bundle was obtained in the same manner as in Example 1, except that the temperature from the spinning polymer stock solution to the filter was maintained at 80 ° C and the nozzle temperature was 65 ° C. The resulting hollow fiber membrane had an inner diameter of 201.1 μm and a film thickness of 30.6 μm. It was 4.5 mass% when the mass ratio of the hydrophilic polymer in a hollow fiber membrane was measured. When the yarn strength of the hollow fiber was measured, the breaking strength was 15.1 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membrane thus obtained and conducting a leak test, no leak due to breakage or breakage of the hollow fiber was observed. The production conditions and evaluation results of the hollow fiber membrane of Example 5 are shown in Table 1.
(比較例1)
紡糸ポリマー原液のタンクからフィルターまでの温度を40℃に保持した以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は200.5μm、膜厚は30.3μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.6質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり12.3gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所が血液浄化器中の中空糸膜束10000本中平均2本確認された。比較例1の中空糸膜の製造条件及び評価結果を表1に示す。
(Comparative Example 1)
A hollow fiber membrane bundle was obtained in the same manner as in Example 1, except that the temperature from the spinning polymer stock solution to the filter was maintained at 40 ° C. The obtained hollow fiber membrane had an inner diameter of 200.5 μm and a film thickness of 30.3 μm. The mass ratio of the hydrophilic polymer in the hollow fiber membrane was measured and found to be 4.6 mass%. When the yarn strength of the hollow fiber was measured, the breaking strength was 12.3 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membranes thus obtained and conducting a leak test, the leak location due to hollow fiber breakage and breakage was an average of 10,000 hollow fiber membrane bundles in the blood purifier. Two were confirmed. The production conditions and evaluation results of the hollow fiber membrane of Comparative Example 1 are shown in Table 1.
(比較例2)
紡糸ポリマー原液のタンクからフィルターまでの温度を75℃に保持し、ノズル温度も75℃とした以外、実施例1と同様にして中空糸膜束を得た。得られた中空糸膜の内径は200.2μm、膜厚は30.5μmであった。中空糸膜中の親水性ポリマーの質量割合を測定したところ、4.7質量%であった。中空糸の糸強度を測定したところ破断強力は中空糸1本あたり11.5gであった。このようにして得られた中空糸膜を用いて血液浄化器を組み立て、リーク試験を行った結果、中空糸の折れ、切れ起因によるリーク箇所が血液浄化器中の中空糸膜束10000本中平均55本確認された。比較例2の中空糸膜の製造条件及び評価結果を表1に示す。
(Comparative Example 2)
A hollow fiber membrane bundle was obtained in the same manner as in Example 1, except that the temperature from the spinning polymer stock solution to the filter was maintained at 75 ° C and the nozzle temperature was also 75 ° C. The resulting hollow fiber membrane had an inner diameter of 200.2 μm and a film thickness of 30.5 μm. When the mass ratio of the hydrophilic polymer in the hollow fiber membrane was measured, it was 4.7% by mass. When the yarn strength of the hollow fiber was measured, the breaking strength was 11.5 g per hollow fiber. As a result of assembling a blood purifier using the hollow fiber membranes thus obtained and conducting a leak test, the leak location due to hollow fiber breakage and breakage was an average of 10,000 hollow fiber membrane bundles in the blood purifier. 55 were confirmed. The production conditions and evaluation results of the hollow fiber membrane of Comparative Example 2 are shown in Table 1.
本発明の製造方法で得られたポリスルホン系中空糸膜は、高い強度と透水性を有し、しかも血液浄化器作製時の歩留りを高い水準で維持することができる。従って、本発明のポリスルホン系中空糸膜の製造方法は、上記特性を有したポリスルホン系中空糸膜を経済的に、かつ安定して製造することができる。 The polysulfone-based hollow fiber membrane obtained by the production method of the present invention has high strength and water permeability, and can maintain a high yield when producing a blood purifier. Therefore, the method for producing a polysulfone-based hollow fiber membrane of the present invention can economically and stably produce a polysulfone-based hollow fiber membrane having the above characteristics.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009168347A JP2011020071A (en) | 2009-07-17 | 2009-07-17 | Method for manufacturing polysulfone-based hollow fiber membrane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009168347A JP2011020071A (en) | 2009-07-17 | 2009-07-17 | Method for manufacturing polysulfone-based hollow fiber membrane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011020071A true JP2011020071A (en) | 2011-02-03 |
Family
ID=43630599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009168347A Pending JP2011020071A (en) | 2009-07-17 | 2009-07-17 | Method for manufacturing polysulfone-based hollow fiber membrane |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011020071A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016182015A1 (en) * | 2015-05-13 | 2016-11-17 | 東洋紡株式会社 | Porous hollow fiber membrane and manufacturing method therefor |
| CN113828162A (en) * | 2020-06-23 | 2021-12-24 | 三达膜科技(厦门)有限公司 | Preparation method of sustainable hydrophilic modified polyvinylidene fluoride hollow membrane |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005021510A (en) * | 2003-07-04 | 2005-01-27 | Toyobo Co Ltd | Highly permeabile hollow fiber type hemocatharsis device |
| JP2007289886A (en) * | 2006-04-26 | 2007-11-08 | Toyobo Co Ltd | Polymeric porous hollow fiber membrane |
| WO2008093654A1 (en) * | 2007-01-30 | 2008-08-07 | Toray Industries, Inc. | Hollow-fiber membrane and hollow-fiber-membrane module having the same included therein |
-
2009
- 2009-07-17 JP JP2009168347A patent/JP2011020071A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005021510A (en) * | 2003-07-04 | 2005-01-27 | Toyobo Co Ltd | Highly permeabile hollow fiber type hemocatharsis device |
| JP2007289886A (en) * | 2006-04-26 | 2007-11-08 | Toyobo Co Ltd | Polymeric porous hollow fiber membrane |
| WO2008093654A1 (en) * | 2007-01-30 | 2008-08-07 | Toray Industries, Inc. | Hollow-fiber membrane and hollow-fiber-membrane module having the same included therein |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016182015A1 (en) * | 2015-05-13 | 2016-11-17 | 東洋紡株式会社 | Porous hollow fiber membrane and manufacturing method therefor |
| CN113828162A (en) * | 2020-06-23 | 2021-12-24 | 三达膜科技(厦门)有限公司 | Preparation method of sustainable hydrophilic modified polyvinylidene fluoride hollow membrane |
| CN113828162B (en) * | 2020-06-23 | 2022-12-20 | 三达膜科技(厦门)有限公司 | Preparation method of sustainable hydrophilic modified polyvinylidene fluoride hollow membrane |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5754654B2 (en) | Porous hollow fiber membrane for protein-containing liquid treatment | |
| JP5504560B2 (en) | Hollow fiber membrane for liquid processing | |
| CN104602798B (en) | Permselective asymmetric membrane | |
| JP6433513B2 (en) | Porous hollow fiber filtration membrane | |
| EP3216515B1 (en) | Hollow fiber filtration membrane | |
| JP6024660B2 (en) | Porous hollow fiber membrane | |
| JP5720249B2 (en) | Hollow fiber membrane, method for producing the same, and blood purification module | |
| US20150060372A1 (en) | Low cut-off ultrafiltration membranes | |
| CA2921827A1 (en) | Porous membrane, blood purifying module incorporating porous membrane, and method for producing porous membrane | |
| JP2792556B2 (en) | Blood purification module, blood purification membrane and method for producing the same | |
| EP3246085A1 (en) | Porous hollow fiber membrane | |
| JP5440332B2 (en) | Hollow fiber membrane | |
| JPH10108907A (en) | Membrane for hemocatharsis, its preparation and module for hemocatharsis | |
| JP5212837B2 (en) | Permselective hollow fiber membrane | |
| JP2011050881A (en) | Method of spinning hollow fiber membrane | |
| JP2020533166A (en) | Microporous membrane and its manufacturing method | |
| JP4103037B2 (en) | Diaphragm cleaning hollow fiber membrane and method for producing the same | |
| JP2011020071A (en) | Method for manufacturing polysulfone-based hollow fiber membrane | |
| JPH11309355A (en) | Polysulfone hollow fiber type blood purifying membrane and its production | |
| JP4029312B2 (en) | Permselective hollow fiber membrane | |
| WO1996035504A1 (en) | Hollow-fiber membrane of polysulfone polymer and process for the production thereof | |
| WO2022240782A1 (en) | Polymeric membrane and methods for the production of same | |
| JPH09220455A (en) | Hollow yarn type selective separation membrane | |
| JPWO2016182015A1 (en) | Porous hollow fiber membrane and method for producing the same | |
| JP2005021510A (en) | Highly permeabile hollow fiber type hemocatharsis device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120403 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120918 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120921 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121009 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130712 |